UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 88

Sortiert nach

Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5801

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review

International journal of molecular sciences, 2020-11, Vol.21 (21), p.8362

2020

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin in Liver Cancer Therapy

International journal of molecular sciences, 2023-06, Vol.24 (13), p.10858

2023

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review

Cancers, 2021-01, Vol.13 (3), p.514

2021

Link zum Volltext

Verfügbarkeit prüfen

The Roles of Epigenetic Regulation and the Tumor Microenvironment in the Mechanism of Resistance to Systemic Therapy in Hepatocellular Carcinoma

International journal of molecular sciences, 2023-02, Vol.24 (3), p.2805

2023

Link zum Volltext

Verfügbarkeit prüfen

Alcohol-related cancer morbidity and mortality are stratified using modified albumin platelet product

Scientific reports, 2024-01, Vol.14 (1), p.1052-1052, Article 1052

2024

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA Interference in Hepatic Host-Pathogen Interactions

International journal of molecular sciences, 2021-03, Vol.22 (7), p.3554

2021

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs and Nonalcoholic Steatohepatitis: A Review

International journal of molecular sciences, 2023-10, Vol.24 (19), p.14482

2023

Link zum Volltext

Verfügbarkeit prüfen

Galectin-9 in Gastroenterological Cancer

International journal of molecular sciences, 2023-03, Vol.24 (7), p.6174

2023

Link zum Volltext

Verfügbarkeit prüfen

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model

PloS one, 2022-02, Vol.17 (2), p.e0261310-e0261310

2022

Link zum Volltext

Verfügbarkeit prüfen

Diabetes mellitus and metformin in hepatocellular carcinoma

World journal of gastroenterology : WJG, 2016-07, Vol.22 (27), p.6100-6113

2016

Link zum Volltext

Verfügbarkeit prüfen

Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma

American journal of physiology: Gastrointestinal and liver physiology, 2020-03, Vol.318 (3), p.G401-G409

2020

Link zum Volltext

Verfügbarkeit prüfen

Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C

Hepatology research, 2019-07, Vol.49 (7), p.731-742

2019

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest

International journal of oncology, 2017-12, Vol.51 (6), p.1674-1684

2017

Link zum Volltext

Verfügbarkeit prüfen

Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients

BMC gastroenterology, 2024-04, Vol.24 (1), p.123-123

2024

Link zum Volltext

Verfügbarkeit prüfen

Cancer Therapy Due to Apoptosis: Galectin-9

International journal of molecular sciences, 2017-01, Vol.18 (1), p.74-74

2017

Link zum Volltext

Verfügbarkeit prüfen

Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up

Internal Medicine, 2021/06/15, Vol.60(12), pp.1835-1838

2021

Link zum Volltext

Verfügbarkeit prüfen

Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study

Hepatology international, 2023-06, Vol.17 (3), p.606-614

2023

Link zum Volltext

Verfügbarkeit prüfen

Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1667

2022

Link zum Volltext

Verfügbarkeit prüfen

Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest

Oncology reports, 2017-11, Vol.38 (5), p.2825-2835

2017

Link zum Volltext

Verfügbarkeit prüfen

Correlation between serum galectin‐9 levels and liver fibrosis

Journal of gastroenterology and hepatology, 2018-02, Vol.33 (2), p.492-499

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy

Cancers, 2023-03, Vol.15 (6), p.1834

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of probable autoimmune hepatitis patients: a single-center study in Japan

Internal and emergency medicine, 2021-11, Vol.16 (8), p.2155-2162

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(86)
Berichte
(2)

Sprache

Englisch
(80)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review

Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review

Cisplatin in Liver Cancer Therapy

MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review

The Roles of Epigenetic Regulation and the Tumor Microenvironment in the Mechanism of Resistance to Systemic Therapy in Hepatocellular Carcinoma

Alcohol-related cancer morbidity and mortality are stratified using modified albumin platelet product

MicroRNA Interference in Hepatic Host-Pathogen Interactions

MicroRNAs and Nonalcoholic Steatohepatitis: A Review

Galectin-9 in Gastroenterological Cancer

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model

Diabetes mellitus and metformin in hepatocellular carcinoma

Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma

Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C

Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest

Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients

Cancer Therapy Due to Apoptosis: Galectin-9

Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up

Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study

Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines

Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest

Correlation between serum galectin‐9 levels and liver fibrosis

Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy

Prognosis of probable autoimmune hepatitis patients: a single-center study in Japan

Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct-acting antiviral treatment: All Kagawa Liver Disease Group Study

Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy

Suchergebnisse filtern